A rich past


Since 1979, Emmer-Compascuum has been playing a leading role in the development of the technology and production of systems related to innovative infusion and transfusion therapies for seriously and/or chronically ill patients.

The Red Cross

The success story started in 1939 at the Dutch Red Cross. The Dutch Red Cross started a partnership with the medical corps of the armed forces under the name of “Amsterdamse Conserveerinrichting Noord” (North Conservation Institution of Amsterdam). The goal of this body was to store blood for a long period and to provide blood transfusion equipment. These activities were taken over in 1943 by the Het Centraal Laboratorium van de Bloedtransfusiedienst (CLB; The Central Laboratory of the Blood Transfusion Department).

The production of blood transfusion equipment and disposables was taken over in 1979 by the NPBI (Nederlandse Productielaboratorium voor Bloedtransfusieapparatuur en Infusievloeistoffen; Dutch Production Laboratory for Blood Transfusion Equipment and Infusion Solutions) that established itself in Emmer-Compascuum and became the largest employer of the region. This laid the foundations for the current Fresenius Kabi organisation.

Fresenius Kabi and the Fresenius Group

Fresenius Kabi is part of the Fresenius Group that originated in Germany and was set up in 1912. The group operates globally. Fresenius Kabi is the leading organisation in relation to transfusion technology. Fresenius Kabi is represented in the Netherlands by a marketing and sales organisation based in Zeist and a production site in Emmer-Compascuum. Essential components are produced in Emmer-Compascuum for innovative blood separation systems that are used globally by hospitals and blood banks. This concerns high-quality components for:

  1. Apheresis equipment for cell separation
    It is intended to separate blood when it is taken from the donor into different components.
  2. Continuous autologous transfusion systems
    They are used to wash and separate blood lost during operations and to return it to the patent through transfusion.

Fresenius Kabi in Emmer-Compascuum has its own laboratory and employs more than 200 employees.


Fresenius Kabi will be working on the production of blood transfusion equipment and disposables until approximately 2024. As of 2021, our activities will also focus on the production of medical nutrition (clinical nutrition) and we will produce millions of clinical nutrition bags of a high quality.